Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX)
CAPS Rating:
The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.
The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.
Recs
May be very worth the speculation at this price